FDA Grants GRAS Status to Probiotic Strain CP-9 for Safe Use in Foods
September 15, 2025 — Taipei, Taiwan Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core...
Advertisement
AMO Pharma Reports Long-Term Safety Data of AMO-02 in DM1
LONDON, Sept. 15, 2025 – AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company dedicated to rare genetic...
Sciton Unveils HALO® TRIBRID™: A Revolution in Skin Resurfacing
Palo Alto, California – September 15, 2025 – Sciton, Inc., a leader in medical aesthetic laser and light-based technology,...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Ronovo Surgical Launches Advanced Sutures for Better Healing
DALLAS, Texas, September 12, 2025 — Ronovo Surgical has announced the launch of its latest line of advanced surgical...
Elutia Sells BioEnvelope Business to Boston Scientific for $88 Million
MALVERN, Pennsylvania, September 10, 2025 — Elutia has announced the sale of its BioEnvelope business to Boston Scientific Corporation...
Silexion’s SIL204 Shows Preclinical Promise in Pancreatic Cancer
GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Private Equity Firm GTCR to Acquire Zentiva from Advent, Expanding Pharma Reach
Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...
Zhimeng Biopharma Wins Approval to Launch Phase 2 Epilepsy Trial
Shanghai, China – September 11, 2025 – Shanghai Zhimeng Biopharma, Inc. today announced that its investigational therapy CB03-154, a...
Advertisement
